<DOC>
	<DOCNO>NCT01589081</DOCNO>
	<brief_summary>The propose clinical study analyze interaction progesterone , nicotine , alteration endocrine hormone , mood cardiovascular measure . It hypothesize administration progesterone dose mimic luteal phase level normal cycle woman diminish positive subjective effect nicotine , consistently observe cocaine . This novel approach could direct implication facilitate smoke cessation treatment woman reproductive age</brief_summary>
	<brief_title>Effects Progesterone IV Nicotine-Induced Changes Hormones Subjective Ratings Stimulant Drug Effect</brief_title>
	<detailed_description>These clinical study design examine effect progesterone IV nicotine induce change anterior pituitary ( ACTH , LH , Prolactin ) adrenal hormone ( DHEA cortisol ) . We also plan study norepinephrine ( NE ) epinephrine ( E ) , nicotine stimulate rapid release NE E preclinical clinical study . The study examine acute effect progesterone effect IV nicotine HPG axis . Progesterone 's influence acute effect nicotine gonadal steroid hormone ( estradiol , testosterone , progesterone ) unknown . The effect progesterone nicotine induce change gonadal steroid hormone reciprocal feedback regulation LH also examine . The temporal covariance progesterone influence hormonal change serum nicotine level nicotine-induced change subjective state cardiovascular measure analyze . Finally , covariance effect progesterone nicotine-induced change endocrine , subjective cardiovascular effect temporal concordance increase serum nicotine cotinine level determine .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Women age 18 40 currently smoke least 15 cigarette every day , fulfill DSMIV diagnostic criterion nicotine dependence eligible participation . No evidence clinically significant disease base upon complete medical history physical examination supervise Dr. Arthur Siegel ( Chief Internal Medicine ) . Absence DSMIV Axis I Disorders nicotine dependence ( 305.10 ) measure Structured Clinical Interview ( SCID ) . Routine laboratory blood test include complete blood count , electrolytes , BUN creatinine , liver function test , hepatitis panel urinalysis perform . Laboratory parameter must within normal range . HBsAg must negative subject hepatitis serology consistent previous exposure Hepatitis A , Hepatitis B , Hepatitis C , clinical biochemical evidence acute infection , acceptable . Hematocrit level ≥ 35 % female . Serum pregnancy test ( hCG beta subunit ) result must negative within 24 hr study session day . Normal EKG . A Body Mass Index ( BMI—ratio weight ( W ) height ( H ) square ; W/H2=kg/m2 ) 18.0 27.0 woman . Subjects must able read understand instruction , well provide valid informed consent . Participants lifetime DSMIV Axis I disorder nicotine dependence . Participants clinically significant medical disorder . Women pregnant determine laboratory test serum beta hCG . Women use hormonal contraceptive medication accept , would confound hormonal measure . Women mean BMI outside range 18.027.0 . Subjects peanut/peanut oil allergy exclude . Participants diagnose lactose intolerance exclude . Participants describe seek treatment select refer local smoking cessation program .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>